July 14, 2011

A new study conducted by Bayer HealthCare suggests that an investigational treatment for acne may be suitable for patients with dark complexions whose acne includes a condition that causes irregular discoloration of the skin known as postinflammatory hyperpigmentation, or PIH.

July 14, 2011

Hyperpigmentation is a common, usually harmless condition that can be caused by a host of factors. While treatments are plentiful, many contain the controversial ingredient hydroquinone. Enter La Roche-Posay's Mela-D Pigment Control concentrated dark spot correcting serum, which does not contain hydroquinone.

September 15, 2010

Ethnic beauty brand Black Opal has announced the launch of its new Fade systems to...

July 18, 2010

Heather Woolery-Lloyd, a certified dermatologist, has focused her research on developing treatments for the cosmetic...